Back to news
finance

Darling Ingredients Secures Patent for Advanced Collagen Peptide Technology

Darling Ingredients has been granted a U.S. patent for Rousselot’s innovative Nextida GC collagen peptide. This intellectual property covers a new method for producing highly functional, taste-neutral collagen peptides, enhancing their application in food and beverage products.

7/23/2026, 12:46:15 PM

Darling Ingredients, a global developer of sustainable natural ingredients, has announced the acquisition of a United States patent for its Rousselot brand’s Nextida GC collagen peptide. This patent solidifies the protection of a novel production process leading to a refined collagen, according to Yahoo Finance. This recently secured intellectual property centers on a distinct enzymatic treatment applied to collagen. This innovative methodology yields a collagen peptide that possesses heightened functionality and a neutral taste profile, distinguishing it from conventional collagen products. The Rousselot team has been dedicated to advancing collagen science, and this patent reflects a significant stride in that endeavor. The Nextida GC collagen peptide is engineered to offer superior properties for integration into various food and beverage formulations. Its improved solubility and sensory characteristics make it particularly suitable for applications where taste neutrality and ease of incorporation are paramount. The global demand for collagen ingredients continues to expand, driven by increasing consumer interest in health and wellness products. Collagen peptides are widely recognized for their potential benefits in skin health, joint support, and muscle recovery. The development of advanced collagen forms, such as Nextida GC, addresses the market need for more versatile and palatable options. Darling Ingredients emphasizes its commitment to innovation within the specialty ingredients sector. This patent award underscores the company's strategy to invest in research and development, aiming to deliver cutting-edge solutions to its customers worldwide. The company anticipates that this patented technology will further strengthen its position in the competitive hydrocolloid and protein markets. The company’s Rousselot division specializes in gelatin and collagen peptides, serving diverse industries including pharmaceuticals, food, and nutrition. This latest patent is expected to bolster the portfolio of proprietary technologies that Rousselot offers, potentially opening new avenues for product development and market penetration.

Share